Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan.
Saved in:
| Title: | Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan. |
|---|---|
| Authors: | Howden CW; University of Tennessee College of Medicine, Memphis, TN 38163, USA., Cook EE; Analysis Group, Inc., Boston, MA, USA., Swallow E; Analysis Group, Inc., Boston, MA, USA., Yang K; Analysis Group, Inc., New York, NY, USA., Guo H; Analysis Group, Inc., Los Angeles, CA, USA., Pelletier C; Phathom Pharmaceuticals, Florham Park, NJ, USA., Jacob R; Phathom Pharmaceuticals, Florham Park, NJ, USA., Sugano K; Jichi Medical University, Shimotsuke, Tochigi, Japan. |
| Source: | Therapeutic advances in gastroenterology [Therap Adv Gastroenterol] 2023 May 02; Vol. 16, pp. 17562848231168714. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Publications Country of Publication: England NLM ID: 101478893 Publication Model: eCollection Cited Medium: Print ISSN: 1756-283X (Print) Linking ISSN: 1756283X NLM ISO Abbreviation: Therap Adv Gastroenterol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
